Daniel L. Alkon
Board Member
TAO Synergies Inc. (TAOX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Daniel L. Alkon
Daniel L. Alkon is recorded as Board Member at TAO Synergies Inc. (TAOX). TAO Synergies Inc. reported in an 8-K filed June 9, 2025 that Daniel L. Alkon resigned as director, effective June 4, 2025. TAO Synergies Inc. reported in an 8-K filed December 21, 2023 that Daniel L. Alkon was appointed Director, effective December 20, 2023.
“On June 4, 2025, Dr. Daniel L. Alkon resigned as an officer, director and Chief Science Officer of the Company to become a consultant working with the Company's newly established Bryostatin Development Committee (the "Committee"), consisting of Mr. William Singer and Mr. Joshua Silverman.”
“Our stockholders voted to elect two directors to hold office until the 2026 annual meeting of stockholders, and until their respective successors are elected and qualified, by the following votes:”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-12-20–present
-
Start not stated–2025-06-04
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at TAO Synergies Inc.
Other people whose current roles at this company are on record from its filings.
- Bruce T. Bernstein Chairman
- Joshua N. Silverman Chairman
- Joshua Silverman Chairman
- Robert Weinstein CFO
- Alan Tuchman Board Member
- Jonathan L. Schechter Board Member
- Robert Ephron Board Member
- William S. Singer Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.